14-day Premium Trial Subscription Try For FreeTry Free
NYSE:CRXM
Delisted

Taxus Cardium Pharmaceuticals Group, Inc Stock Price (Quote)

New York Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: Nov 10, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Thursday, 10th Nov 2022 CRXM stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0001

Historical Taxus Cardium Pharmaceuticals Group, Inc prices

Date Open High Low Close Volume
2022-11-10 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-09 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-08 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-07 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-04 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-03 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-02 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-11-01 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-31 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-28 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-27 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-26 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-25 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-24 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-21 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-20 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-19 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-18 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-17 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-14 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-13 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-12 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-11 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-10 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-10-07 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Taxus Cardium Pharmaceuticals Group, Inc

Taxus Cardium Pharmaceuticals Group Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced ... CRXM Profile

Golden Star

Ticker Date Change Price
LXP Apr 05 0.790% $8.86
AKR Apr 05 4.23% $16.53
SARK Mar 28 12.46% $26.88
ARCC Mar 25 0.596% $20.12
STT Mar 19 3.18% $72.62
GGB Mar 19 4.45% $4.27
LNC Mar 18 2.61% $27.17
CAG Mar 18 5.46% $28.22
CMC Mar 14 4.83% $53.19
MASI Mar 14 4.47% $132.20
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT